Jerome Cambre - 18 Jan 2024 Form 4 Insider Report for VIEMED HEALTHCARE, INC. (VMD)

Role
Vice President of Sales
Signature
/s/ Jesse Bergeron, Attorney-in-Fact
Issuer symbol
VMD
Transactions as of
18 Jan 2024
Net transactions value
-$13,053
Form type
4
Filing time
22 Jan 2024, 17:36:24 UTC
Previous filing
19 Jan 2024
Next filing
30 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VMD Common Shares Options Exercise +4,805 +6.7% 76,170 18 Jan 2024 Direct F1
transaction VMD Common Shares Tax liability $13,053 -1,713 -2.2% $7.62 74,457 18 Jan 2024 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VMD Restricted Stock Units Options Exercise $0 -4,805 -50% $0.000000 4,804 18 Jan 2024 Common Shares 4,805 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share.
F2 Shares that were withheld by the issuer to satisfy the reporting person's tax obligation resulting from the vesting of restricted stock units.
F3 Per share value is based on the market closing price of the common shares for January 18, 2024.
F4 Restricted Stock Units (RSUs) granted to reporting person on January 18, 2022, which vest in three equal annual installments beginning on the first anniversary of the grant date.